Document is current
Any future updates will be listed below
-
Authors
Blin, Patrick http://orcid.org/0000-0003-4005-7928
Darmon, Patrice
Henry, Patrick
Guiard, Estelle
Bernard, Marie-Agnès
Dureau-Pournin, Caroline
Maizi, Hélène
Thomas-Delecourt, Florence
Lassalle, Régis
Droz-Perroteau, Cécile
Moore, Nicholas
-
Funding
Funding for this research was provided by:
astrazeneca
- License Information
-
More Information
Article History
Received: 9 August 2021
Accepted: 12 November 2021
First Online: 25 November 2021
Declarations
:
: The study received approval from the National Institute of Health Data (<i>Institut National des Données de Santé</i>—<i>INDS</i>) on July 18th, 2018 and then authorization from French data protection authority (<i>Commission Nationale de l’Informatique et des Libertés</i>—<i>CNIL</i>) on September 17th, 2018. SNDS is a pseudonymized database and no individual patient consent was required. This study complied with all regulations including GDPR and it was registered in the European database of post-approval studies (ExternalRef removed) as EUPAS27402.
: All authors give their consent for the publication of information contained in this article to be published in Cardiovascular Diabetology.
: None of the authors benefited personally from this funding, except some of their salary during the study period, and fees for PD and PH for their participation to the scientific committee of the study.
